Group One Trading
JUNO

Group One Trading’s Juno Therapeutics, Inc. JUNO Stock Holding History

Group One Trading’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-235,700
Closed -$10.8M – 5684
2017
Q4 		$10.8M Buy
235,700
+96,900
+70% +$4.83M 0.08% 317
2017
Q3 		$6.23M Buy
138,800
+49,900
+56% +$1.7M 0.06% 420
2017
Q2 		$2.66M Buy
88,900
+8,600
+11% +$212K 0.03% 787
2017
Q1 		$1.78M Sell
80,300
-36,800
-31% -$789K 0.02% 942
2016
Q4 		$2.21M Sell
117,100
-78,700
-40% -$1.93M 0.02% 866
2016
Q3 		$5.88M Buy
195,800
+119,200
+156% +$3.71M 0.06% 347
2016
Q2 		$2.94M Sell
76,600
-1,700
-2% -$70.6K 0.03% 612
2016
Q1 		$2.98M Buy
78,300
+41,900
+115% +$1.46M 0.04% 569
2015
Q4 		$1.6M Sell
36,400
-125,400
-78% -$6.22M 0.02% 1008
2015
Q3 		$6.58M Buy
161,800
+106,000
+190% +$4.65M 0.09% 259
2015
Q2 		$2.98M Buy
55,800
+41,200
+282% +$2.19M 0.04% 535
2015
Q1 		$886K Buy
+14,600
New +$709K 0.01% 1183

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Group One Trading's JUNO Position: Q3 2017 in Review

Group One Trading sold out of Juno Therapeutics, Inc. (JUNO) in Q3 2017, closing a stake of 79,579 shares — an estimated $2.71M sold.

Group One Trading first reported a position in JUNO in Q1 2015 and held it in 9 quarters. The position peaked at $2.91M in Q4 2016. 210 funds tracked by Wall St. Rank hold JUNO as of Q3 2017.

  • Group One Trading reported no remaining Juno Therapeutics, Inc. position as of Q3 2017 after selling out during the quarter.
  • Group One Trading sold 79,579 Juno Therapeutics, Inc. shares in Q3 2017, an estimated $2.71M.
  • Group One Trading first reported a position in Juno Therapeutics, Inc. in Q1 2015 and held it in 9 quarters.
  • Group One Trading's Juno Therapeutics, Inc. position peaked at $2.91M in Q4 2016.
  • 210 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q3 2017.

Based on Group One Trading's 13F filing for Q3 2017, filed 15 Nov 2017.